Evidence map›Paper›PMID 36318727›Full record

ArticleAnalytical chemistry2022

Causes of Industrial Protein A Column Degradation, Explored Using Raman Spectroscopy.

James W Beattie, Alena Istrate, Annabelle Lu, Cameron Marshall, Ruth C Rowland-Jones, Monika Farys, Sergei G Kazarian, Bernadette Byrne

Abstract read
In one paragraph

Article in Analytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

James W BeattieDepartment of Life Sciences, Imperial College London, LondonSW7 2AZ, United Kingdom.ORCID 0000-0003-4028-0150
Alena IstrateBiopharm Process Research, Medicine Development & Supply, GSK R&D, Gunnels Wood Road, Stevenage, HertfordshireSG1 2NY, United Kingdom.
Annabelle LuDepartment of Life Sciences, Imperial College London, LondonSW7 2AZ, United Kingdom.
Cameron MarshallDepartment of Life Sciences, Imperial College London, LondonSW7 2AZ, United Kingdom.
Ruth C Rowland-JonesBiopharm Process Research, Medicine Development & Supply, GSK R&D, Gunnels Wood Road, Stevenage, HertfordshireSG1 2NY, United Kingdom.
Monika FarysBiopharm Process Research, Medicine Development & Supply, GSK R&D, Gunnels Wood Road, Stevenage, HertfordshireSG1 2NY, United Kingdom.
Sergei G KazarianDepartment of Chemical Engineering, Imperial College London, LondonSW7 2AZ, United Kingdom.ORCID 0000-0003-1768-9134
Bernadette ByrneDepartment of Life Sciences, Imperial College London, LondonSW7 2AZ, United Kingdom.ORCID 0000-0001-9598-9832

Funding

Biotechnology and Biological Sciences Research Council BB/R019533/1Biotechnology and Biological Sciences Research Council BB/S506965/1
6 · The paper itself

Abstract

Monoclonal antibodies (mAbs) are used extensively as biotherapeutics for chronic and acute conditions. Production of mAbs is lengthy and expensive, with protein A affinity capture the most costly step, due both to the nature of the resin and its marked reduction in binding capacity with repeated use. Our previous studies using in situ ATR-FTIR spectroscopy indicated that loss in protein A binding capacity is not the result of leaching or degradation of protein A ligand, suggesting fouling is the principal cause. Here we explore binding behavior and resin capacity loss using Raman spectroscopy. Our data reveal a distinct Raman spectral fingerprint for mAb bound to the protein A ligand of MabSelect SuRe. The results show that the drop in static binding capacity (SBC) previously observed for used protein A resin is discernible by Raman spectroscopy in combination with partial least-squares regression. The SBC is lowest (35.76 mg mL

Indexed as

Spectrum Analysis, RamanStaphylococcal Protein AAntibodies, MonoclonalChromatography, AffinityLigandsAntibodies, MonoclonalLigandsStaphylococcal Protein A

Identifiers

PMID36318727
PMCPMC9670029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.